Press Releases
Aspen highlights the rising diabetes disease burden
Aspen marked World Diabetes Day by highlighting the alarming economic, social, productivity and reduced life expectancy impact that diabetes is having on South Africa
Financial
Aspen building momentum in Commercial Pharmaceuticals and Manufacturing strategy modified
Aspen Pharmacare Holdings has reported financial results for the year ended 30 June 2025, with strong momentum in Commercial Pharmaceuticals and a modified Manufacturing strategy.
SED Initiatives
Aspen celebrates 15 years of commitment to Nelson Mandela Day
The true heroes of our Mandela Day campaign are our employees who continue to volunteer to make a difference through their acts of selfless generosity, humility and care for those in need.
Financial
Aspen delivers strong results and advances its strategic ambitions
Aspen Pharmacare Holdings has reported positive Group interim financial results for the six months ended 31 December 2024.
Press Releases
Aspen announces local availability of Lilly’s Mounjaro
Aspen has announced the availability of Lilly’s tirzepatide, marketed globally as Mounjaro®, a therapeutic option available to physicians for the treatment of Type II diabetes.
Press Releases
Aspen and SEMDSA highlight the alarming rise of non-communicable diseases on World Diabetes Day
Aspen and SEMDSA earlier today raised awareness around the alarming rise of non-communicable diseases, particularly diabetes, in recognition of World Diabetes Day.
Financial
Aspen to participate in the Investec CEO conference in London
Aspen’s Stephen Saad and Sean Capazorio will take part in Investec’s CEO conference in London from 14 to 15 November 2024.
SED Initiatives
Aspen partners with PinkDrive to mobilise cancer screening
Aspen has contributed towards the funding of a new mobile cancer screening clinic for rural and peri-urban disadvantaged communities.
Media Enquiries
Shauneen Beukes
Group Communications Consultant
+27 31 580 8600
+27 82 389 8900
sbeukes@aspenpharma.com